Physician profile
Aron A Barsky
NPI 1023273703
$870.72
in general payments reported to CMS, 2019-2025
21 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $378 · 2020: $155 · 2023: $101 · 2024: $97.29 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $337.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $171.24 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $118.13 | 2019-2024 | Xarelto |
| Abbott Laboratories | $77.87 | 2020-2023 | Tendril |
| Astrazeneca Pharmaceuticals Lp | $52.97 | 2019-2020 | |
| Abiomed | $52.06 | 2025 | |
| Amgen INC. | $44.79 | 2019-2025 | Repatha |
| Sanofi-Aventis U.S. LLC | $41.29 | 2019-2020 | |
| Pfizer INC. | $39.31 | 2019-2020 | |
| G Medical Diagnostic Services, INC. | $29.76 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.01 | 2019 | |
| Baxter Healthcare | $26.88 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Arbor Pharmaceuticals, INC. | $26.59 | 2019 | |
| Novartis Pharmaceuticals Corporation | $26.26 | 2019 | |
| Gilead Sciences, INC. | $24.84 | 2019 | |
| Philips North America LLC | $18.88 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $18.53 | 2020 | |
| Edwards Lifesciences Corporation | $17.69 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.49 | 2023 | Lifevest |
| Kiniksa Pharmaceuticals International, Plc | $14.70 | 2024 | Arcalyst |
| Kowa Pharmaceuticals America, INC. | $11.76 | 2019 | |
| Boston Scientific Corporation | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aron Barsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.